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Introduction
Unusual cases of acute cholecystitis and cholangitis in-
clude: (1) pediatric biliary tract infections, (2) geriatric 
biliary tract infections, (3) acalculous cholecystitis, (4) 
cholangitis accompanying hepatolithiasis and intra-
hepatic cholangitis, (5) acute biliary tract infections 
accompanying malignant pancreatic biliary tumor, (6) 
postoperative biliary tract infections, (7) acute biliary 
tract infections accompanying congenital biliary dilata-
tion and pancreaticobiliary maljunction, and (8) pri-
mary sclerosing cholangitis.
This article discusses the characteristics, diagnostic 
criteria, treatment guidelines, and prognoses of these 
unusual types of biliary tract infection in a question and 
answer format.
Pediatric biliary tract infections
Q1.  What are the causes of pediatric cholangitis 
and cholecystitis?
Abstract
Unusual cases of acute cholecystitis and cholangitis include 
(1) pediatric biliary tract infections, (2) geriatric biliary tract 
infections, (3) acalculous cholecystitis, (4) acute and intrahe-
patic cholangitis accompanying hepatolithiasis (5) acute bili-
ary tract infection accompanying malignant pancreatic-biliary 
tumor, (6) postoperative biliary tract infection, (7) acute bili-
ary tract infection accompanying congenital biliary dilatation 
and pancreaticobiliary maljunction, and (8) primary scleros-
ing cholangitis. Pediatric biliary tract infection is characterized 
by great differences in causes from those of adult acute biliary 
tract infection, and severe cases should be immediately re-
ferred to a specialist pediatric surgical unit. Because biliary 
tract infection in elderly patients, who often have serious sys-
temic conditions and complications, is likely to progress to a 
serious form, early surgery or biliary drainage is necessary. 
Acalculous cholangitis, which often occurs in patients with 
serious concomitant conditions, such as those in intensive care 
units (ICUs) and those with disturbed cardiac, pulmonary, 
and nephric function, has a high mortality and poor prognosis. 
Cholangitis accompanying hepatolithiasis includes recurrent 
pyogenic cholangitis, an epidemic disease in Southeast Asia. 
Biliary tract infections, which often occur after a biliary tract 
operation and treatment of the biliary tract, may have a fatal 
outcome, and should be carefully observed. The causes of 
acute cholangitis associated with pancreaticobiliary maljunc-
tion differ before and after operation. Direct cholangiography 
is most useful in the diagnosis of primary sclerosing cholangi-
tis. If cholangiography visualizes a typical bile duct, differen-
tiation from acute pyogenic cholangitis is easy. This article 
discusses the individual characteristics, diagnostic criteria, 
treatment guidelines, and prognosis of these unusual types of 
biliary tract infection.
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The causes of pediatric acute biliary tract infec-
tions are quite different from those of adult acute 
biliary tract infection.
Pediatric acute biliary tract infection is a rare disease, 
occurring most often in children (less than 15 years old) 
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aticobiliary maljunction, or after liver transplantation. 
Ascending cholangitis (hereinafter “cholangitis”) 
occurs in as many as 50% of children after operation for 
biliary atresia, and these children should therefore be 
monitored carefully (level 4). The condition often oc-
curs within a year after the operation.
Acute cholecystitis occurs very rarely (0.13%–0.22%) 
in children as compared with the incidence in adults. 
According to a review of 693 cases, conducted in 1989 
by Friesen and Roberts,1 the ages when pediatric cho-
lecystitis occurs are distributed as follows: 9.8% (1 year 
old or younger), 4.5% (1–5 years old), 14.5% (6–10 
years old), and 71.5% (age, 11–20 years) (level 3b-4). 
The causes of pediatric acute cholecystitis, including 
hemolytic hematopathy, congenital malformations, 
intravenous hyperalimentation, ileectomy, and short-
bowel syndrome, are different from those of adult cho-
lecystitis (level 3b-4).2,3 Pediatric acalculous cholecystitis 
has various causes, mainly serious burns and metabolic 
diseases, and it occurs after serious operations and bone 
marrow transplantation. Pediatric acalculous cholecys-
titis is very rare and accounts for only 2%–15% of all 
types of acute cholecystitis in children (level 4).4
Q2.  What are the diagnostic criteria for pediatric acute 
biliary tract infection?
The majority of pediatric acute cholangitis occur in 
children who have undergone biliary operations for 
such diseases as biliary atresia and cholangiectasis, and 
those with liver transplantation. For children with ab-
dominal pain and fever as the main complaints, it is es-
sential to ask their past history of disease and surgery. 
If they have a history of the above diseases, the diag-
nosis should be performed with acute biliary tract 
infection in mind. The above diagnostic guidelines for 
pediatric cholangitis are not evidence-based, but are 
only draft guidelines.
Almost all patients with post-biliary atresia cholan-
gitis have a fever of 38  °C or over. Reduced biliary 
excretion volume, leukocytosis, elevated levels of C-
reactive protein, bilirubin in plasma, and alkaline phos-
phatase may be observed in some patients (level 4).5–7 
However, fever is the only ﬁ  nding observed in all pa-
tients, and even fever caused by a viral infection or 
cold-induced dyspepsia may often cause cholangitis 
with dehydration or reduced systemic immunity. 
In view of the fact that nearly half of those patients 
with fever and reduced biliary excretion (gray-white 
stool) later show an elevated plasma level of bilirubin, 
it is preferable to begin early treatment for those 
with fever as the only symptom, with the potential 
of cholangitis in mind. Therefore, patients with fever 
after operation for biliary atresia should be suspected 
of having acute cholangitis, and should receive treat-
ment similar to that for acute cholangitis. Differentia-
tion from other frequent diseases in children, such as 
acute pharyngitis and acute viral enteritis (rota-virus 
enteritis) is important. However, if these diseases are 
present after biliary atresia operation or liver trans-
plantation in children, the diagnosis becomes more 
difﬁ  cult.
Acute cholangitis in children without a history of 
surgery should be diagnosed comprehensively with 
ultrasonographic, blood biochemical, and pathological 
ﬁ  ndings, with the possibility of acute cholangitis always 
in mind.
The diagnosis of pediatric acute cholangitis should 
be done in accordance with the draft diagnostic, 
criteria shown below. Precautions should be tak-
en, particularly for patients after operation for 
biliary atresia.
For the diagnosis of pediatric acute cholecysti-
tis, the draft diagnostic criteria shown below 
should be referred to.
Draft diagnostic criteria for pediatric acute 
cholecystitis
Patients with symptoms such as fever and abdom-
inal pain and ﬁ  ndings of cholecystitis on abdomi-
nal ultrasonography are deﬁ  nitely diagnosed as 
having acute cholecystitis.
Fever, vomiting, right hypochondrial tenderness, ab-
dominal pain (spontaneous pain), and jaundice are im-
portant ﬁ  ndings in the diagnosis of acute cholecystitis 
(level 4).4 Blood biochemical tests show elevated white 
blood cell counts, plasma bilirubin, alkaline phospha-
tase, asparatate aminotransferase, and alanine amino-
transferase (level 4).4  Abdominal ultrasonography is 
Draft diagnostic criteria for pediatric acute 
cholangitis
Children after an operation for biliary atresia who 
have a fever of 38  °C or higher are diagnosed as 
having suspected acute biliary tract infection.
Children after a biliary atresia operation or af-
ter liver transplantation who have a fever of 38 °C 
or higher, and an increased white blood cell count 
or increased C-reactive protein, and/or increased 
transaminase level are deﬁ  nitely diagnosed hav-
ing as acute cholangitis.
Those with sludge or gallstones in the bile duct 
observed by abdominal ultrasonography, a fever 
of 38  °C or higher, an increased white blood cell 
count or increased C-reactive protein, and/or in-
creased transaminase level are deﬁ  nitely diag-
nosed as having acute cholangitis.100  H. Yasuda et al.: Tokyo Guidelines for unusual cases of acute cholangitis and cholecystitis
useful for diagnosis in children, as well as for adults 
(level 3b-4).2,4
Q3.  What are the appropriate criteria for primary care 
and patient transfer?
and older)”, “medium elderly (75 and older)”, and “lat-
er elderly (85 years and older)”. The ages at which bili-
ary tract infections occur most frequently are the sixties 
and seventies, and many patients with biliary tract infec-
tion are categorized as “elderly”. The deﬁ  nition of 
“elderly” employed in the references and reports on 
geriatric biliary tract infection is diverse, but it is useful 
to classify geriatric biliary tract infection at the higher 
age for understanding and identifying morbid condi-
tions speciﬁ  c to geriatric patients. The Tokyo Guide-
lines deﬁ  ne biliary tract infections in those 75 years and 
over as “geriatric biliary tract infections”.
Q4.  What treatment method is preferred for 
elderly patients?
Primary care for pediatric acute biliary tract infec-
tion consists of: (1) fasting, (2) adequate intrave-
nous ﬂ  uid infusion, and (3) intravenous 
antimicrobial administration. Patients should be 
transferred, as required, to a specialist pediatric 
unit, according to the criteria below.
Primary care should be started and patients should be 
referred to a pediatric surgery unit if they have a history 
of biliary tract surgery or deﬁ  nitive cholangitis.
Primary care for pediatric acute biliary tract infection 
consists of: (1) fasting, (2) adequate intravenous ﬂ  uid 
infusion, and (3) intravenous antimicrobial administra-
tion, and the patients should be referred or transferred, 
as required, to a specialist unit where treatment by 
pediatricians is available, according to the above 
criteria.
As various causative bacteria for cholangitis occur-
ring after a biliary atresia operation, broad spectrum 
antimicrobial drugs are effective as their bactericidal ef-
fect on enterobacteria, which are mainly gram-negative 
bacilli, is high (level 4).8 A third-generation cephem an-
timicrobial, or in some cases, an aminoglycoside antimi-
crobial as well, should therefore be administered, taking 
the production of drug-resistant bacteria into account 
(level 4–5).6,8 However, treatment of the cholangitis that 
may occur after an operation for biliary atresia is directly 
associated with the prognosis of the biliary atresia, and 
whether or not the cholangitis is successfully controlled 
is associated with an indication for liver transplantation; 
therefore, patients should undergo the treatment at a 
specialist unit after undergoing primary care.
The primary care of cholecystitis consists, in principle, 
of fasting (aspiration of stomach contents via a nasogas-
tric tube as appropriate), adequate intravenous ﬂ  uid 
inffusion, and intravenous administration of appropriate 
antimicrobial drugs, and this should be accompanied by 
strict ultrasonographic follow-up (level 4).4,9 As chole-
cystitis in infants is likely to progress to a severe form, 
emergency treatment may be required in some cases.
Geriatric biliary tract infections
There is no common deﬁ  nition of “elderly”, and deﬁ  ni-
tions differ by individuals, culture, and country. The 
World Health Organization deﬁ  nes the elderly as those 
aged 65 years and over. Geriatrically, the deﬁ  nition of 
“elderly” is subdivided into “early elderly (65 years old 
Biliary drainage is the treatment of choice for 
moderate or severe acute cholangitis in elderly 
patients (recommendation C).
Acute cholangitis in elderly patients often progresses to 
a serious form or to acute obstructive suppurative chol-
angitis, because of its anatomical characteristics. In pa-
tients 70 years and over with jaundice, this is likely to 
be accompanied by bactibilia and bacteremia, and they 
may require hospitalizion for a long period of time. 
Preferably, these patients should undergo early drain-
age. However, in view of the fact that elderly patients 
often have complications, there are many opinions that 
the ﬁ  rst treatment should be endoscopic biliary drainage 
rather than an invasive treatment. Endoscopic biliary 
drainage is applicable for elderly patients. Reports that 
the success rate of endoscopic lithotomy was 98% in 101 
patients 75 years and over when endoscopic retrograde 
cholangiopancreatography (ERCP) was applied (level 
4),1 and that ERCP was applied in 23 patients 90 years 
and over (level 4),2 and that the success rate of endo-
scopic sphincterotomy (EST) was similar in patients 80 
years and over (182 cases) and younger patients (level 
3b),3 encourage diagnosis and treatment with ERCP for 
elderly patients. One report recommends endoscopic 
nasobiliary drainage (ENBD) without sphincterotomy 
as the method of ﬁ  rst choice in the treatment of elderly 
patients 80 years and over (level 3b),4 while an other 
report suggests percutaneous transhepatic drainage 
(level 4).5 Because being elderly is one of the risk factors 
for progression to a severe form, as described in the se-
verity classiﬁ  cation, even those with moderate and mild 
cases of acute cholangitis should be treated as a high-risk 
group.
Q5.  What are the morbid conditions in 
acute cholecystitis?
It is known that acute cholecystitis occurs frequently in 
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biliary tract structure and a frequent incidence of bac-
teria in bile. As acute cholecystitis in patients over 70 
years old is often complicated by acalculous cholecysti-
tis, choledocholithiasis, gallbladder necrosis, and can-
cer, and is likely to be associated with bacteremia, the 
importance of early treatment is indicated (level 3b).6 
The complication of peritonitis increases in proportion 
to age, and the complication rate in patients in their 
eighties is signiﬁ  cantly higher than that at other ages. 
According to Andersson et al.,7 biliary peritonitis was 
observed in 1.8% of patients with acute cholecystitis, 
two-thirds of whom showed clear gallbladder perfora-
tion. On the other hand, as the three-layer structure 
and the thickening of the gallbladder wall, which are 
frequently observed on abdominal ultrasonography in 
acute cholecystitis patients 75 years and over, are not 
observed in many “later” elderly patients, the diagnosis 
is difﬁ  cult in many of these patients.
Q6.  What is the optimal treatment of acute 
cholecystitis in elderly patients diagnosed as inoperable 
due to a high surgical risk?
years and over, in view of its favorable results (level 3b). 
Another study reports that, because, in the elderly aged 
70 years and over, cholecystectomy as emergency sur-
gery is likely to be complicated by sepsis, resulting in a 
mortality as high as 10% (level 4),12 the emergency sur-
gery should be avoided. For acute cholecystitis in the 
elderly aged 70 years and over, primary care to improve 
the systemic condition with PTGBD prior to cholecys-
tectomy reduces the postoperative mortality and mor-
bidity rates (level 4),10 and delayed cholecystectomy is 
recommended only after the disappearance of inﬂ  am-
mation, by applying PTGBD to carefully examine and 
treat accompanying diseases, including choledocholi-
thiasis (level 4).13 In a contrasting ﬁ  nding, a group of 
patients who underwent early surgery after PTGBD 
showed better results than those not undergoing PTG-
BD or those undergoing delayed surgery after PTGBD: 
the higher the success rate of intraoperative cholangi-
ography, the lower was the rate of conversion to open 
surgery and the shorter the time of operation (level 
3b).14 No conclusion has been reached on the timing of 
surgery for acute cholecystitis in the elderly. In view of 
their worse systemic condition and more complications 
in general, including choledocholithiasis, as compared 
with younger patients, elderly patients should receive 
surgery only after careful and adequate examination of 
their systemic condition.
Q8.  What surgical method should be applied for acute 
cholecystitis in the elderly?
Percutaneous transhepatic gallbladder drainage is 
the treatment of choice for the elderly with acute 
cholecystitis who are diagnosed as inoperable due 
to a high surgical risk (recommendation C).
Some reports (case-series studies) have examined the 
effectiveness and safety of percutaneous transhepatic 
gallbladder drainage as the treatment of ﬁ  rst choice for 
acute cholecystitis in elderly patients, particularly in 
those with comorbid conditions, and they indicate its 
usefulness (level 4).8–10 The treatment of acalculous cho-
lecystitis can be completed without cholecystectomy if 
the patiens’ condition is successfully improved by per-
cutaneous transhepatic gallbladder drainage (PTGBD) 
(level 4).10  For patients complicated by cholelith, on 
the other hand, cholecystectomy is recommended, ulti-
mately, if patients are operable after the improvement 
of their systemic condition (level 4).10
Q7.  What is the optimal timing of surgical treatment 
for acute cholecystitis in elderly patients?
Emergency surgery for acute cholecystitis in el-
derly patients (recommendation C).
According to randomized controlled trials (RCTs), ear-
ly surgery is desirable for acute cholecystitis (7 days af-
ter the onset). Studies on the timing of surgery for acute 
cholecystitis in the elderly, most of which are retrospec-
tive, have recommended both early and delayed 
surgery. Edlund and Liungdahl11 recommend early cho-
lecystectomy for acute cholecystitis in the elderly 70 
Cholecystectomy for acute cholecystitis in the 
elderly (recommendation grade C).
Laparoscopic cholecystectomy is desirable in 
all eligible patients (recommendation C).
After the introduction and popularization of laparo-
scopic cholecystectomy, its superiority has been report-
ed in an increasing number of studies. Laparoscopic 
cholecystectomy performed for acute cholecystitis in 
the elderly 75 years and over requires a shorter time of 
operation and a shorter length of hospitalization, and 
reduces the number of patients who need rehabilitation 
and the mortality rate, as compared with open cholecys-
tectomy (level 3b).15 The mortality rate of laparoscopic 
cholecystectomy is the same as that of open cholecys-
tectomy (level 4).16 The morbidity rate of open chole-
cystectomy is about seven times higher than that of 
laparoscopic cholecystectomy, and the elderly and high-
risk patients in higher American Society of Anesthesiol-
ogy (ASA) Physical Class System classes should undergo 
laparoscopic cholecystectomy (level 3b).17 Laparoscopic 
cholecystectomy performed in the elderly 75 years and 
over reduces the morbidity rate and shortens the dura-
tion of hospitalization, and thus reduces medical costs 102  H. Yasuda et al.: Tokyo Guidelines for unusual cases of acute cholangitis and cholecystitis
(level 3b).18 There is a report, in contrast, that laparo-
scopic cholecystectomy for elderly patients 75 years and 
over is not very beneﬁ  cial, because many of the elderly 
need to undergo open cholecystectomy later and to stay 
in hospital for the same length of time as those with 
open cholecystectomy (level 3b).19 There is an opinion 
that laparoscopic cholecystomy is preferable, similarly 
to delayed surgery, for patients without complications, 
whereas for patients 65 years and over with complica-
tions, early conversion to open cholecystectomy or the 
performance of open cholecystectomy is recommended 
(level 3b).20
Acalculous cholecystitis
Q9.  What are the points to be considered in the 
diagnosis of acalculous cholecystitis?
with acute acalculous cholecystitis, respectively, with a 
mortality of 41% (level 4).6 However, Ryu et al.7 re-
ported that gangrenous changes and perforation were 
observed in 55% and 5.1% of patients with acute acal-
culous cholecystitis, respectively, while there were no 
fatal cases (level 4). A review of 33 case-series studies, 
including that by Kang and Williamson,1 showed a total 
mortality of 15% (91 of 594 patients died) while the 
mortality of post-trauma patients was high, at 27% 
(level 4). Table 1 shows risk factors for acute acalculous 
cholecystitis. According to a survey by Ida et al.,8 of 145 
medical institutions, 14 654 patients subjected to opera-
tion for benign biliary disorders in the 3 years from 
1979 through 1981 included 463 (3%) with acalculous 
cholecystitis and 93 (0.6%) with acalculous cholangitis 
(level 4).
Q11.  What are the risk factors for acute 
acalculous cholecystitis?
Acute acalculous cholecystitis is likely to occur during 
the treatment of serious conditions such as trauma and 
burns, and in postoperative patients (Table 1). It is re-
ported that the incidence of acute acalculous cholecys-
titis rises with the increasing number of patients with 
Table 1.  Factors potentially associated with acute acalculous 
cholecystitis (Review of Barie and Fischer19)
Risk factor  Reference nos.
Surgery
  Heart operation  14, 16–18
  Heart transplantation  20–23
  Aortic aneurysm  11–13
Trauma
Burn
Diabetes 32–34
Abdominal angitis  14, 30
Spreading of malignant tumor involving  27
  the hepatic hilus
Congestive heart failure, hypotension  31
  caused by hemorrhagic shock and after
  cardiac arrest
Iatrogenic
  Interleukin 2 therapy, lymphokine-  34
    activated killer cell therapy
  Percutaneous transhepatic biliary  40
    drainage
  After bone marrow transplantation  35
Spread of infection from other sites
  Systemic candida infection  36
  Leptospirosis 37
  Tuberculosis
  Salmonella infection of the bile duct  38–39
  AIDS 41–42
Closure of entrahepatic bile ducts due to
  rare cause
  Bloody bile
  Echinococcosis cyst
•    Acalculous cholecystitis occurs often in patients 
with severe acute cholecystitis.
•    The prognosis of acalculous cholecystitis is 
worse than that of ordinary acute cholecystitis.
•    Acalculous cholecystitis may be relieved by bili-
ary drainage alone in some cases.
Acalculous cholecystitis often occurs in patients in the 
intensive care unit (ICU) and in those with cardio-
pulmonary-nephrotic dysfunction. The total mortality 
is 15%, with the post-trauma mortality as high as 
27% (level 4).1
Q10.  What are the incidence and prognosis of acute 
acalculous cholecystitis?
•    Acute acalculous cholecystitis accounts for 
2%–15% of acute cholecystitis. Common risk 
factors of acalculous cholecystitis are operation, 
serious trauma, burns, and parenteral nutrition. 
It is also reported that the spread of malignant 
tumor to the hilus of the liver, hepatic arterial 
infusion, diabetes, speciﬁ  c drugs and speciﬁ  c 
infections are associated with acalculous chole-
cystitis. According to reports of Japanese pa-
tients, acute acalculous cholecystitis occurs 
often after an abdominal operation.
Acute acalculous cholecystitis accounts for 2%–15% of 
all types of acute cholecystitis (level 4).2–5 Acalculous 
cholecystitis is likely to occur in patients with serious 
disease, and has a poor prognosis in general, due to the 
high incidence of morbidity, such as gangrenous chole-
cystitis and gallbladder perforation. According to 
Kalliafas et al.,6 gangrenous changes, perforation, and 
abscess are observed in 63%, 15%, and 4% of patients H. Yasuda et al.: Tokyo Guidelines for unusual cases of acute cholangitis and cholecystitis  103
severe disease and increasingly complicated treatment 
procedures.9,10
Factors associated with postoperative acute cholecystitis
Table 2 shows the incidence of postoperative acute cho-
lecystitis after various operations. After aortic aneurysm 
repair, particularly ruptured aneurysm, the incidence of 
acute cholecystitis is high. In aortic aneurysm patients, 
the incidence of acute cholecystitis after the repair of 
non-ruptured aneurysm is around 1%,11–13 but the inci-
dence after the repair of a ruptured aneurysm is as high 
as 13.6% (level 4).11 Although the incidence of acute 
cholecystitis after cardiac surgery is not very high 
(0.12%–0.94%),14–18  surgery combining valve replace-
ment and coronary artery bypass is considered as a risk 
factor for postoperative acute cholecystitis. A compari-
son of 30 patients with post-cardiovascular operation 
acute cholecystitis and 11 300 who underwent the opera-
tion at the same time but showed no acute cholecystitis 
indicates that those subjected to surgery combining 
valve replacement and coronary artery bypass account-
ed for 23% (7/30) of patients with acute cholecystitis, 
but 11% (1299/11 300; P = 0.03) of those without appear-
ance of the disease (level 3c).14 After cardiac transplan-
tation, postoperative cholecystitis appears at higher 
incidences (0.7%–5.7%).20–22 Postoperative cholecystitis 
occurs at similar frequencies in both calculous and acal-
culous patients.19 The incidence of postoperative acute 
calculous cholecystitis is the same in male and female 
patients, whereas acalculous cholecystitis is more likely 
to occur in male patients. According to a review by 
Inoue and Mishima23 of 494 postoperative acute chole-
cystitis patients at 122 institutions over 10 years from 
1976 until 1985, the incidence of postoperative acute 
cholecystitis was 0.06%. Of the 494 postoperative acute 
cholecystitis patients, 445 cases were acalculous (90%) 
(level 4) and occurred at an average age of 60 years. 
Postoperative acute cholecystitis occurs more frequently 
in male patients (2.8 times more than in female patients) 
after abdominal operations (435 cases) and most fre-
quently after gastrectomy (level 4).
Post-trauma and burns
Acute acalculous cholecystitis is likely to occur after 
trauma or burns. According to Kang and Williamson,1 
12%–49% of acute acalculous cholecystitis occurs after 
trauma or after critical surgery (level 4). The incidence 
of post-trauma acute cholecystitis is 3.7% in those with 
spinal cord injury (7 of 191 cases; acalculous cholecys-
titis only) and 18% in those with multiple injuries (8 of 
45 cases; both acalculous and calculous) (level 4).24 Ac-
cording to Raunest et al.,24 90% of post-trauma acute 
cholecystitis in patients who underwent intensive care 
of multiple injuries was acalculous. Because trauma pa-
tients are mostly young males, it can be said that post-
trauma acute cholecystitis occurs mostly in males.
Parenteral nutrition
Long-term parenteral nutrition causes cholestasis. Gall-
stones are observed in a high percentage of those 
subjected to parenteral nutrition for over 3 months. Ac-
cording to a study by Pitt et al.,25 observing 71 patients 
undergoing parenteral nutrition for 3 months and over, 
11 (15%) patients had cholecystolithiasis prior to the 
start of nutrition and 21 (35%) of the remaining 60 pa-
tients were found to have cholecystolithiasis during par-
enteral nutrition (level 4). Patients undergoing long-term 
parenteral nutrition show a higher incidence of not only 
calculous but also acalculous cholecystitis. According to 
Peterson and Sheldon,26 acute acalculous cholecystitis 
was observed in 4% of patients undergoing central par-
enteral nutrition (level 4).
Table 2.  Incidence of postoperative acute cholecystitis
Author  Year of report  Characteristics  No. of cases  Incidence (%)
Ouriel12  1984  Aneurysm repair      703   1.1
Scher11  1986  Aortic aneurysm repair, elective       352    1.0
    Aortic aneurysm repair, emergency         22  13.6
Hagino13  1997  Aortic aneurysm  repair      996   1.0
Barie15  1993 Cardiac  surgery  31  710    0.12
Sessions16  1993  Cardiac surgery   6  393   0.34
Leitman14  1987  Cardiac surgery   6  452   0.94
Savino17  1985  Cardiac surgery   2  100   0.24
Welling18  1986 Cardiac  surgery    1  596
Steed20  1985 Cardiac  transplantation        142    0.7
Merrell21  1989 Cardiac  transplantation        178    2.2
Rakhit22  2002  Pediatric cardiac  transplantation      105   5.7
Takahashi43  1990 Gastrectomy    1  096    0.6
Saito44  1997 Cardiac  surgerya    1 015    0.6
Ishikawa45  1997 Cardiovascular  surgery        321    1.2
Note: Prepared mainly based on the review by Barie and Fischer,19 including acalculous cholecystitis
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Malignant tumor
Gastric cancer, and tumors of the liver, biliary tract, and 
pancreas, as well as melanoma and breast cancer, if they 
spread to obstruct the cystic duct, may cause acute cal-
culous cholecystitis (level 4).27
Hepatic artery infusion
Hepatic artery infusion may be associated with drug 
toxicity and catheter complications. According to an 
examination by Barnett and Malafa28 of complications 
in 3991 patients subjected to hepatic artery infusion, 
and the study of Lafon et al.,29 the incidence of biliary 
complications, including acute cholecystitis, was 4% 
(level 4).
Other factors
Other factors associated with the occurrence of biliary 
and other types of acute acalculous cholecystitis include 
abdominal vasculitis,30 hemorrhagic shock, and cardiac 
arrest31 (level 4 for all cases).
With respect to a correlation between diabetes and 
acute cholecystitis, a report indicates that the incidence 
of infectious complications in acute cholecystitis is in-
creased in diabetics (level 3b),32 while on other report 
indicates that diabetes does not increase the risk of 
cholecystectomy in those with acute cholecystitis (level 
2c).33
Acute acalculous cholecystitis has been observed in 
patients who have undergone interleukin-2 and lym-
phokine-activated killer cell therapy35 and bone marrow 
transplantation.35
Acute acalculous cholecystitis may occur as a second-
ary gallbladder infection following systemic candidiasis 
or leptospirosis,36–37 or it may occur with Salmonella typhi 
as causative bacteria38,39 (level 4 for references 36–39).
An examination of acalculous cholecystitis in patients 
with cerebral vascular disorder in the acute stage showed 
an incidence of acalculous cholecystitis of 1%, which is 
almost equal to the post-trauma and postoperative 
incidence.
Q12.  What is the best method for the diagnosis of 
acute acalculous cholecystitis?
As many patients with acalculous cholecystitis are in 
ICUs (with extubation) due to complications, clinical 
signs highly speciﬁ  c for calculous acute cholecystitis, 
such as sonographic Murphy’s sign, are often useless 
in these, acalculous, patients. Cholescintigraphy is very 
sensitive, but is less speciﬁ  c, with a high false-positive 
rate, in disease resulting from total parenteral nutrition, 
fasting, or liver failure. On abdominal ultrasonography 
and CT, (1) thickened gallbladder wall, (2) perichole-
cystic ﬂ  uid, and (3) subserous edema are useful signs 
for diagnosis. But their speciﬁ  city is lower than that in 
calculous cholecystitis.47,48 Therefore, for infectious dis-
eases which occur during the treatment of severe dis-
ease with an unknown cause, the possibility of acalculous 
cholecystitis should always be kept in mind. If the pos-
sibility of acalculous cholecystitis cannot be denied be-
cause of the absence of a focus of infection, percutaneous 
biliary drainage should be performed, for both micro-
bial inspection and treatment. However, antimicrobial 
drugs have usually been administered to most of the 
patients, the positive rate of biliary culture is not 
high (33%)(level 4).48,49  Table 3 lists ﬁ  ndings for the 
accuracy of diagnostic imaging in acalenlous acute 
cholecystitis.
Q13. Can  ultrasonography  diagnose 
acalculous cholecystitis?
The diagnosis of acalculous cholecystitis is not easy, 
because it is difﬁ  cult to collect information on abdomi-
nal pain and Murphy’s sign in patients who have disease 
often associated with disturbance of consciousness 
that is or with treatment already received for other 
purposes.50
Jeffrey and Sommer51 examined 14 patients with clini-
cally suspected acalculous cholecystitis, and reported 
that the possibility of acalculous cholecystitis was high 
if the thickness of the gallbladder wall at the ﬁ  rst exami-
nation was normal (3 mm or less) but had increased to 
4 mm or more at the second examination within in 24 h 
(4 out of 4 cases). If the second inspection revealed that 
the thickness remained the same or had improved in 
patients with an abnormally thickened gallbladder wall 
at the ﬁ  rst inspection, the incidence of acalculous cho-
lecystitis was low (1 of 6 cases)(level 4). Helbich et al.,52 
who performed ultrasonography in 21 ICU patients 
weekly, indicated that when 2 points were allotted to an 
enlarged gallbladder (long axis diameter, 8 cm or more; 
short axis diameter, 5 cm or more), thickened gallblad-
der wall (4 mm or more), and an image of debris, and 1 
point to a striated intra-wall structure and ﬂ  uid collec-
tion localized to the pericholecystic area, the incidence 
of acalculous cholecystitis was zero in patients with 5 
points or less but high in those with 6 points or more 
(level 4).
Abdominal echo and computed tomography (CT) 
are useful in the diagnosis of acute acalculous cho-
lecystitis, but care should be taken, as the diagnos-
tic accuracy is lower than that in calculous 
cholecystitis.
Acute acalculous cholecystitis is likely to occur postop-
eratively and during the treatment of serious injuries 
and burns, and accounts for 2%–15% of all acute cho-
lecystitis cases. The diagnosis is difﬁ  cult, and, in Japan, 
the diagnostic accuracy of postoperative cholecystitis at 
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What is hepatolithiasis?
Hepatolithiasis is a condition in which stones are pres-
ent in the hepatic and/or intrahepatic bile duct. Seventy 
to eighty percent of cases of hepatolithiasis are of un-
known cause. In countries in Asia, the incidence of 
hepatolithiasis differs depending on the country; thus, 
environmental factors are considered to be involved in 
the onset.1 Causes can be identiﬁ  ed for the hepatolithia-
sis that occurs secondary to surgery and is associated 
with biliary dysplasia. Speciﬁ  c disorders include Orien-
tal cholangiohepatitis, known as recurrent pyogenic 
cholangitis, an epidemic disease in Southeast Asia.
Epidemiology and etiology of hepatolithiasis
According to a study by Uchiyama and Tanimura,2 
acute cholangitis was observed in 8.5% of 1708 patients 
with hepatolithiasis. Cholelithiasis consists of bilirubin-
calcium stones in 74.8% of patients and cholesterol 
stones in 13.1%, but the etiology of this disease is un-
known. However, in view of the fact that hepatolithiasis 
is not observed in western countries (although it has 
been reported that Escherichia coli is involved in cho-
leithiasis), biliary tract infection is very unlikely to be a 
single cause of hepatolithiasis. There is a report suggest-
ing the involvement of parasites and malnutrition.3 Clo-
norchiosis is asymptomatic when the count of Clonorchis 
sinensis remains low; however, when the count increases 
to 500–1000 pieces, disorders such as closure of the bile 
duct, suppurative cholangitis, and hepatolithiasis may 
occur. In the diagnosis of this disease, the presence of 
eggs in feces or bile, and eosinophilia on blood tests, are 
important ﬁ  ndings. A survey conducted by Sasaki et al.4 
in 1998 in the Goto region, Nagasaki Prefecture, known 
as a region epidemic for hepatolithiasis in Japan, showed 
that HLA antigen positivity (A26, B44, BW54, CW7, 
DR6) was a parameter for a high risk of hepatolithiasis. 
It is also known that the formation of mucin protein on 
the bile duct epithelium plays an important role in the 
formation of stones.4
In view of these reports indicating difﬁ  culty with the 
initial ultrasonographic diagnosis of acalculous chole-
cystitis, it is important to re-examine patients suspected 
of having acalculous cholecystitis.
Q14.  What is the treatment policy for 
acalculous cholecystitis?
In principle, the treatment policy for acalculous 
cholecystitis is the same as that for calculous cho-
lecystitis, but the treatment method is chosen by 
keeping the patients systemic condition in mind.
Basic primary care must be performed before the diag-
nosis is established. As acalculous cholecystitis is 
unlikely to respond to conservative treatment and is 
often complicated by gangrene (with or without perfo-
ration), early cholecystectomy seems to be desirable 
(level 4).53–55 Recently, noninvasive PTGBD has been 
employed for acalculous cholecystitis, which is often 
observed in postoperative and post-trauma patients 
who are regarded as inoperable. There have been no 
RCTs which compared PTGBD and cholecystectomy, 
and the comparison in a retrospective study (level 5)55 
was unreliable because PTGBD was performed in pa-
tients who were inoperable. Some reports examining 
PTGBD performed for elderly patients or those in poor 
systemic condition indicate that PTGBD, which leads 
to a low incidence of recrudescence could replace sur-
gery (recommendation grade B, level 4–5).48,49,56
Acute and intrahepatic cholangitis associated with 
intrahepatic stones
Q15.  How is hepatolithiasis diagnosed as a primary 
disease associated with acute cholangitis?
Patients who have symptoms of cholangitis and 
show localized enlargement or stenosis of an in-
trahepatic bile duct branch, by ultranosonography 
and/or CT, are suspected of having hepatolithia-
sis. For a deﬁ  nite diagnosis, the presence of stones 
should be conﬁ  rmed by direct cholangiography, 
and bile culture and cytodiagnosis should be per-
formed (recommendation C).
Table 3.  Diagnostic imaging accuracy for acalculous acute cholecystitis
  Abdominal ultrasonography  Abdominal CT  Cholescintigraphy
Author Sensitivity  Speciﬁ  city Sensitivity  Sensitivity  False  positive
Blankenberg 23%  (3/13)
Savoca 28%  (5/18)
Swayne 58%  (7/12)      91%
Mirvis  92% (13/14)  96%  86% (6/7)  97% (18/19)  54% (13/24)
Kang 36%–89%      83%–100%
Review by Babb48
Absence of ﬁ  gures for numbers of cases means absence of the number in the original references cited in this Table106  H. Yasuda et al.: Tokyo Guidelines for unusual cases of acute cholangitis and cholecystitis
Prognosis of hepatolithiasis
Furukawa et al.,5 who observed the long term progress 
of acalculous hepatolithiasis, reported that symptoms 
ultimately appeared in 14 (11.5%) of 122 patients. Until 
the development and popularization of cholangio-
graphic lithotomy, hepatolithiasis often progressed via 
biliary cirrhosis, to hepatic failure because of the re-
peated occurrence of cholangitis. Hepatolithiasis may 
be complicated by biliary cancer. The incidence of com-
plication by biliary cancer differs in different reports, 
but ranges from 2.4% to 17.1%.6–8 As stones and cancer 
are almost always present on the same side, repeated 
cholangitis or cholestasis may be one of the causes of 
the cancer.6,9
Diagnosis of hepatolithiasis
Hepatolithiasis is diagnosed by the presence of stones 
in the intrahepatic bile duct, conﬁ  rmed by direct chol-
angiography. Charcot’s triad (abdominal pain, fever, 
and jaundice) is observed in about 60% of the pa-
tients.10 In severe cases associated with shock and dis-
turbed consciousness, patients may have a reduced 
platelet count and disseminated intravascular coagula-
tion (DIC). Characteristic histological ﬁ  ndings in the 
liver include the growth of cholangioles and inﬂ  amma-
tory cellular inﬁ  ltration in the periportal area.
Blood tests. In general, an increased white blood cell 
count, a high level of hepatobiliary enzymes, and hyper-
bilirubinemia are observed, with hyperamylasemia in 
20% of patients.
Microbial examination. The rate of detection of bacteria 
in bile is 85%, with gram-negatives such as E. coli, Kleb-
siella spp. and Enterobacter spp. as major causative bac-
teria. Enterococcus spp and Pseudomonas aeruginosa 
have been increasingly detected recently.2
Diagnostic imaging
Ultrasonographic diagnosis
A marked dilated extrahepatic bile duct, the presence 
of stones, increased echogenicity in the regional intra-
hepatic portal area, and localized enlargement or stric-
ture of intrahepatic segmental bile duct branches are 
observed. However, there is a pitfall with ultrasonogra-
phy in that an enlarged bile duct may not be visualized 
if it is ﬁ  lled with high-luminance sludge (level 4).11
CT diagnosis
CT diagnosis reveals an enlarged intrahepatic bile duct 
and zonal atrophy of the liver. Splenomegaly may be 
observed in patients with serious liver disorder.12  If 
the bile duct is ﬁ  lled with clay stones as a mold, 
cholelith may not be diagnosed. If there is pneumobilia 
due to previous treatment, CT is more useful than 
ultrasonography.
Cholangiography
Enlargement of the bile duct and stones are observed, 
though enlargement of the intrahepatic bile duct is less 
than that of the extrahepatic bile duct. Cholangiography 
shows ﬁ  ndings such as straightening, rigidity, decreased 
arborization, increased branching angle, acute periph-
eral tapering, and multiple focal strictures of the bile 
duct (level 4).13
Acute biliary tract infection associated with malignant 
pancreatic-biliary tumor
Acute cholangitis
Q16.  What is the principle of medical treatment 
for acute cholangitis associated with malignant 
biliary tumor?
Severity assessment should be performed upon 
the initiation of medical treatment.
The examination should be done quickly to 
identify the feasibility of resection. Biliary drain-
age should be performed in a timely manner.
Malignant pancreatic-biliary tumor sometimes devel-
ops in patients with acute cholangitis, and emergency 
biliary drainage is then required. The acute cholangitis 
observed in these patients occurs in those patients 
in whom (1) endoscopic retrograde cholangiopancrea-
tography (ERCP) has been performed only for diag-
nostic purposes, but not for biliary drainage, and (2) 
those in whom biliary drainage has been performed, 
but, due to troubles such as catheter obstruction, 
an undrained area still remains. No matter how 
severe the acute cholangitis is, either drainage or re-
placement of the catheter is required depending on the 
cause.
When malignant pancreatic-biliary tumor is asso-
ciated with acute cholangitis, an appropriate drainage 
method should be selected according to the site of the 
causative stricture or obstruction (see Q17).
Q17.  Which drainage method should be applied for 
acute cholangitis associated with pancreatic-biliary 
malignancies?
For patients in whom an occlusion in the hepatic hilus 
and bile duct extends upstream, percutaneous transhe-
patic drainage should be the method of ﬁ  rst choice, in 
principle, in view of the concern that endoscopic drain-
age may reduce the accuracy of diagnosis of upstream 
cancer metastases and induce cholangitis in the area of 
poor drainage. However, there are no RCTs comparing 
these two drainage methods, and the choice has been 
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There are no reports that compare endoscopic naso-
biliary drainage (ENBD, or biliary tube stent place-
ment) and percutaneous transhepatic biliary drainage in 
patients with occlusion in the middle and lower bile 
duct. However, at the institutions where staff are skillful 
with endoscopic examinations the tendency is to use 
ENBD without EST as the method of ﬁ  rst choice, while 
at the institutions where staff cannot perform ENBD, 
percutaneous transhepatic biliary drainage is chosen. 
However, as it is often difﬁ  cult to visualize the biliary 
tract clearly when endoscopic drainage is performed, 
percutaneous transhepatic biliary drainage is desirable.
It has been reported that the total morbidity and 
mortality rates after pancreaticoduodenectomy in pa-
tients who had occlusion in the middle and lower bile 
duct and received stenting (stent material not speciﬁ  ed), 
were not different from those without stenting, but 
there was a signiﬁ  cantly higher incidence of pancreatic 
ﬂ  uid leakage in those with stenting (level 4).1 Postopera-
tive ﬁ  stula recurrence has been reported after percuta-
neous transhepatic biliary drainage employed for 
patients with biliary tract carcinoma (level 4).2
Acute cholecystitis
Q18.  What is the primary care policy for acute 
cholecystitis complicated by gallbladder cancer?
postoperatively with gallbladder cancer, two-stage radi-
cal surgery is indicated if the cancer is categorized as in 
the proper muscular layer or deeper. However, it is ex-
tremely difﬁ  cult to choose the optimal surgical method, 
based on an assessment of the development of morbid-
ity, in patients with cancer associated with extremely 
severe inﬂ  ammation. A diagnosis of gallbladder cancer 
after laparoscopic cholecystectomy is a risk factor 
for carcinomatous peritonitis and port-site recurrence. 
Therefore, for patients with acute cholecystitis associ-
ated with or suspected to be associated with gallbladder 
cancer, as soon as primary care is initiated, a preopera-
tive examination should be conducted to enable a one-
stage radical operation whenever possible.
Biliary cytodiagnosis (rinsing cytodiagnosis and, aspi-
ration cytodiagnosis) with PTGBD is useful for the di-
agnosis of gallbladder cancer. However, the drainage 
tubes used in PTGBD have interfered with diagnostic 
imaging or have induced recurrence of cancer at the 
drainage ﬁ  stula in some patients. Therefore, it must be 
noted that biliary drainage for acute cholecystitis in pa-
tients with or suspected of having gallbladder cancer 
entails a risk of cancer recurrence at the drainage ﬁ  stula, 
and a risk of carcinomatous peritonitis.
Q19.  What is the treatment policy when acute 
cholecystitis occurs during the surgical treatment of 
gallbladder cancer?
During the preoperative treatment of gallbladder can-
cer, the cystic duct may be obstructed due to the prog-
ress of cancer and/or bile duct stenting, and acute 
cholecystitis may occur. In such a case, PTGBD should 
be performed immediately.
Biliary tract infections in patients with previous 
biliary-tract surgery
Q20.  Is biliary tract infection hidden in 
postoperative patients?
•    Occlusion in the hilus of liver or upstream: per-
form percutaneous transhepatic biliary drain-
age (recommendation C).
•   Occlusion in the middle and lower part of the bile 
duct: perform either endoscopic or percutaneous 
transhepatic biliary drainage, depending on the 
individual’s symptoms and according to the in-
stitutions’ practice (recommendation C).
Severity assessment should be performed simulta-
neously with primary care. Preoperative examina-
tion should be done as early as possible so that a 
one-stage radical procedure can be performed 
whenever possible.
Postoperative biliary drainage, which has a risk of 
recurrence of drainage ﬁ  stula and carcinomatous 
peritonitis, should be avoided whenever possible.
The prognosis of gallbladder cancer complicated by 
acute cholecystitis depends on the degree of progress of 
the cancer itself, but most of these patients have a poor 
prognosis. Preoperative diagnosis is difﬁ  cult when gall-
bladder cancer is complicated by acute cholecystitis, 
and a patient often has surgery after being diagnosed 
with acute cholecystitis, and gallbladder cancer is diag-
nosed intra- or postoperatively. In patients diagnosed 
Patients who have undergone surgery of the bili-
ary tract and the upper abdomen and liver and bili-
ary tract treatment should be observed carefully, 
as cholecystitis and cholangitis may be hidden. Fe-
ver may occur postoperatively, resulting from vari-
ous causes, but the potential association of the 
fever with cholangitis should be borne in mind.
Cholangitis in patients with a history of biliary surgery
Cholangitis in patients with a history of EST and/or en-
doscopic papillary balloon dilatation (EPBD)
As patients with calculous cholangitis often undergo 
cholecystectomy before or after cholelithotomy, there 108  H. Yasuda et al.: Tokyo Guidelines for unusual cases of acute cholangitis and cholecystitis
are not many reports of long-term observations of pa-
tients with gallstones after EPBD, without a surgical 
operation. According to an RCT comparing EST and 
EPBD, the incidence of cholecystitis post-EPBD was 
signiﬁ  cantly lower than that post-EST (9.9% and 1.3% 
after EST and EPBD, respectively) (level 4).1 This is 
because the function of Vater’s papilla is kept intact by 
EPBD, whereas EST causes retroinfection. However, in 
light of the possibility gallstones remaining after EPBD 
and the incidence of conversion to EST in symptomatic 
cholelithiasis patients, more cases should be collected in 
order to identify whether or not cholecystectomy should 
be performed for post-EPBD cholecystolithiasis.
Cholangitis in patients with a history of 
surgical sphincteroplasty
Sphincteroplasty is rarely performed currently because 
of the wide spread use of EST. The incidence of chol-
angitis in patients with sphincteroplasty is about 5.9% 
(level 4).2
Cholangitis in patients with a history of an end-to-side 
choledochojejunostomy
It is reported that postoperative cholangitis occurs in 
9.2%–33% of patients who have had a pancreaticoduo-
denectomy, while 1.1% of patients who have biliary 
surgery need re-surgery. In general, cholangitis is 
caused by the disturbed and retrograde (ascending) 
ﬂ  ow of bile, due to stricture at the site of the 
choledochojejunostomy.
Stenosis at the site of a choledochojejunostomy. Stenosis 
at the site of a choledochojejunostomy was observed in 
7%–23% of those who underwent cholangiojejunosto-
my (level 4),3,4 and it is a frequent cause of postoperative 
cholangitis. The incidence of stenos is higher if malig-
nant tumor-induced stenosis is included.
Afferent loop syndrome. Afferent loop syndrome, in-
duced by the occlusion of an afferent loop arising from 
various causes, may progress to a serious form, so these 
patients should be observed carefully. Afferent loop 
syndrome used to be conﬁ  rmed by dilation of the affer-
ent loop and its stricture on the anal side, shown by 
direct gastrography or diagnosed by ultrasonography 
and/or CT. However, for patients with a crucial stric-
ture, direct gastrography is not applicable and magnetic 
resonance (MR) cholangiopancreatography (MRCP) is 
useful (level 4).4
Retrograde cholangitis and other forms of cholangitis. 
Patients with fever or abdominal pain and increased 
levels of biliary enzymes, such as aspartate aminotrans-
ferase and alanine aminotransferase, and an elevated 
inﬂ  ammatory reaction after treatment or surgery of the 
biliary tract, are often diagnosed as having retrograde 
cholangitis. Pneumobilia and a contrast effect of the bile 
duct wall on CT may be used as supplementary proof 
in the diagnosis, but there are neither speciﬁ  c signs nor 
speciﬁ  c examination ﬁ  ndings. Retrograde cholangitis 
occurs often after treatment or surgery, and is not diag-
nosed, or is missed, in many patients. The absence of 
clear diagnostic criteria for retrograde cholangitis com-
plicates this issue.
Side-to-side choledochojejunostomy
In addition to the problems described above, precau-
tions should be takent to prevent cholangitis (sump syn-
drome) that may be caused by food and sludge collecting 
in the remaining lower bile duct when side-to-side 
choledochojejunostomy.5
End-to-side choledochoduodenostomy
According to an RCT, there is no signiﬁ  cant difference 
in perioperative mortality, the total incidence of mor-
bidity, or the incidence of postoperative cholangitis be-
tween patients who have had a choledochoduodenostomy 
and those who have had a choledochojejunostomy 
(level 4).6
Side-to-side choledochoduodenostomy
Precautions should be taken, because this method 
causes sump syndrome.
Cholangitis and cholecystitis after operations other than 
those on the biliary tract
The incidence of postoperative cholecystitis after sur-
gery other than that on the biliary tract ranges widely, 
from 0.1%–13%, depending on the primary disease and 
surgical method. Patients should be carefully observed 
in view of the high incidence of acalculous 
cholecystitis.
It has been reported that transcatheter arterial embo-
lization (TAE), radiofrequency ablation (RFA), and 
cryosurgery are followed by the occurrence of cholan-
gitis or cholecystitis.7,8 It is difﬁ  cult to identify whether 
these conditions are direct complications of these pro-
cedures. There is a report that intraperitoneal infectious 
diseases (hepatic abscess, intraperitoneal abscess, and 
infection from an inserted device) were observed in 12 
of 158 patients who underwent cryosurgery, with 2 of 
the 12 patients having cholangitis (level 4).8
Post-gastrectomy acute cholecystitis, which is caused 
by intracystic cholestasis (under the inﬂ  uence of re-
duced gallbladder contraction caused by incision of the 
vagus nerve due to lymphadenectomy), disturbed blood 
ﬂ  ow in the gallbladder wall, and bacterial infection, oc-
curred in 24 of 190 patients with gastric cancer (12.6%). H. Yasuda et al.: Tokyo Guidelines for unusual cases of acute cholangitis and cholecystitis  109
Primary sclerosing cholangitis (PSC) is a chronic inﬂ  am-
matory disease with stricture of the bile duct caused by 
progressive and nonspeciﬁ  c inﬂ  ammation of the walls 
of the intra- and extrahepatic bile ducts. It is considered 
that autoimmunity is involved in the onset of PSC. The 
stricture and obstruction of the bile duct may cause ob-
structive jaundice, followed ultimately by secondary 
biliary cirrhosis of the liver and liver failure.
The etiology of PSC has not been identiﬁ  ed. A report 
indicates the involvement of HLA DR3 and DR2 in its 
onset, while there are other reports that bacterial and 
viral infections (associated with immunodeﬁ  ciency), oc-
clusion of the hepatic artery, and disorders induced by 
chemotherapy are involved in the etiology.
Takikawa et al.1 reviewed 388 PSC patients in 2003 
to examine the incidence and prognosis of the disease. 
According to their report, the age distribution of PSC 
patients in Japan has two peaks, one in the twenties and 
the other in the ﬁ  fties to sixties. Younger patients are 
often complicated by inﬂ  ammatory enteropathy, while 
the elderly patients are often complicated by autoim-
mune pancreatitis. It was also reported that the rates of 
complication with ulcerative colitis, autoimmune pan-
creatitis, cholelith, and biliary cancer were 37%, 7.2%, 
16%, and 4.3%, respectively.1
The clinical symptoms of PSC include jaundice (44%), 
systemic itchiness (27%), abdominal pain (18%), fever 
(10%), and systemic weariness (4%). PSC may be com-
plicated by retrograde bacterial cholangitis as a long-
term outcome.2 There are no studies that have conﬁ  rmed 
bacterial cholangitis by examining for the presence of 
bacteria in bile while the patient has a fever, and it is 
not certain whether a fever directly represents the com-
plication of bacterial cholangitis. If PSC presents with 
fever, however, the complication of bacterial cholangitis 
should be suspected. According to Olsson et al.,3 fever 
was observed in 15% of PSC patients and in 50% of 
those whose bile duct lesion was limited to the intrahe-
patic bile duct.
In the diagnosis of PSC, the following diagnostic cri-
teria, proposed by La Russo et al.,4 are often used, ex-
cept for cholelith, post-biliary operation cholangitis and 
secondary sclerosing cholangitis caused by biliary tract 
tumor.
(1)    Increase in the serum alkaline phosphatase level of 
two times or more than the normal level (however, 
patients with an increase of less than two times 
normal account for 35% of PSC cases in Japan)
(2)   Diffuse stricture or bead-like change in the intra- 
and extrahepatic bile ducts
The etiology of acute cholangitis associated with 
congenital biliary dilatation differs according to 
whether it occurs pre- or postoperatively (level 4).
Acute cholangitis associated with congenital biliary dil-
atation is roughly divided into two types: cholangitis as 
a primary symptom of congenital biliary dilatation and 
postoperative cholangitis.
The incidence of acute cholangitis is 9.2%–23.4% in 
patients with congenital biliary dilatation without cho-
ledocholithiasis, with the complication of acute pancre-
atitis in many cases (level 4).1,2 Mechanisms of the onset 
of cholangitis include the backﬂ  ow of pancreatic ﬂ  uid 
into the bile duct and the incarceration of a gallstone 
protein plug in the papilla (level 4).3 Symptoms include 
abdominal pain, vomiting, jaundice, and fever. Abdomi-
nal pain is observed in over 80% of infant patients 1 
year and older. In patients under 1 year old, who very 
rarely have abdominal pain as the main complaint, vom-
iting, fever, and jaundice are important proofs of the 
diagnosis (level 4).4
Postoperative acute cholangitis occurs in 8%–30% of 
patients who undergo an operation for congenital bili-
ary dilatation. Postoperative cholangitis and hepatoli-
thiasis are considered to be caused by stricture at the 
site of a choledochoenterostomy and congenital stric-
ture of the intrahepatic bile duct (level 4).5
Because of the high morbidity of postoperative 
cholangitis, various methods are used at the initial 
operation for congenital biliary dilatation (level 
4).
To prevent postoperative cholangitis, the recommended 
methods are to cut and open the right and left hepatic 
ducts during surgery, to make a large anastomotic open-
ing and to form a passage for the strictured intrahepatic 
bile duct.
Primary sclerosing cholangitis (PSC)
Q22.  How do we differentiate acute cholangitis 
from PSC?
Direct cholangiography is most useful in the diag-
nosis of PSC, and acute pyogenic cholangitis can 
be differentiated easily if a typical cholangiograph is 
observed. If patients with PSC have a fever, compli-
cation by bacterial cholangitis should be borne in 
mind.
Particularly after Appleby surgery, the disease occurred 
frequently, in 10 of 37 patients.9
Acute biliary tract infections associated with congenital 
biliary dilatation and pancreaticobiliary maljunction
Q21.  What is the characteristic etiology of acute 
cholangitis associated with congenital biliary dilatation?110  H. Yasuda et al.: Tokyo Guidelines for unusual cases of acute cholangitis and cholecystitis
(3)   Histological  ﬁ  ndings that include ﬁ  brosed bile duct, 
obstructive cholangitis, and disappearance of bile 
duct
(4)    No history of biliary tract operation other than cho-
lecystectomy, and the absence of cholelith
The diagnostic criteria proposed by the Mayo Clinic 
group in 19945 attach the greatest importance to chol-
angiographic ﬁ  ndings, such as beaded appearance, 
band-like stricture, and diverticulum-like outpouching, 
and this group argues that the diagnosis of PSC only by 
liver biopsy is difﬁ  cult. One of the important issues in 
the diagnosis of PSC is complication by and differentia-
tion from bile duct cancer. As it has been reported that 
7.1% (5/71) of the patients who died of PSC had bile 
duct cancer (cholangiocarcinoma), patients presenting 
with atypical stricture of the bile duct should undergo 
histopathological diagnosis with a biopsy, using percu-
taneous transhepatic cholangiography (PTCS).
Q23.  What is the optimal treatment method for 
localized PSC
preparation of the Guidelines. This process was con-
ducted as part of the Project on the Preparation and 
Diffusion of Guidelines for the Management of Acute 
Cholangitis (H-15-Medicine-30), with a research subsi-
dy for ﬁ  scal 2003 and 2004 (Integrated Research Project 
for Assessing Medical Technology) sponsored by the 
Japanese Ministry of Health, Labour, and Welfare.
We also truly appreciate the panelists who cooper-
ated with and contributed signiﬁ  cantly to the Interna-
tional Consensus Meeting, held on April 1 and 2, 2006.
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